Hematologic malignancies in pregnancy: Management guidelines from an international consensus meeting

Journal of Clinical Oncology

Volumn 34, Issue 5, 2016, Pages 501-508

  Lishner, Michael ^a,b   Avivi, Irit ^c   Apperley, Jane F ^d   Dierickx, Daan ^m   Evens, Andrew M ^g   Fumagalli, Monica ^h   Nulman, Irena ^j   Oduncu, Fuat S ^k   Peccatori, Fedro Alessandro ⁱ   Robinson, Susan ^e   Van Calsteren, Kristel ^l   Vandenbroucke, Tineke ^m   Van Den Heuvel, Frank ^f   Amant, Frederic ^m  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Ichilov Medical Center   (Israel)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g TUFTS MEDICAL CENTER   (United States)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^j HOSPITAL FOR SICK CHILDREN   (Canada)

^k UNIVERSITY OF MUNICH   (Germany)

^l UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^m UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOPTERIN; ANAGRELIDE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BETAMETHASONE; BLEOMYCIN; BRENTUXIMAB VEDOTIN; CORTISONE; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; HYDROXYUREA; IMATINIB; LENALIDOMIDE; METHOTREXATE; METHYLPREDNISOLONE; POMALIDOMIDE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; THALIDOMIDE; VINBLASTINE; VINCRISTINE;

ALLERGIC REACTION; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHRONIC MYELOID LEUKEMIA; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; MONTE CARLO METHOD; MYELOPROLIFERATIVE NEOPLASM; NEONATOLOGIST; NEUTROPENIA; NONHODGKIN LYMPHOMA; NONHUMAN; OBSTETRICS; PERINATAL PERIOD; PHOCOMELIA; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; SKELETON MALFORMATION; SOCIAL WORKER; VOMITING; CONSENSUS; DISEASE MANAGEMENT; HEMATOLOGIC NEOPLASMS; INTERNATIONAL COOPERATION; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; STANDARDS;

CONSENSUS; DISEASE MANAGEMENT; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INTERNATIONAL AGENCIES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS;

EID: 84958744669     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.62.4445     Document Type: Article

References (92)

1. Wang PI, Chong ST, Kielar AZ, et al: Imaging of pregnant and lactating patients: part 1, evidencebased review and recommendations. AJR Am J Roentgenol 198:778-784, 2012
2. Woussen S, Lopez-Rendon X, Vanbeckevoort D, et al: Clinical indications and radiation doses to the conceptus associated with CT imaging in pregnancy: A retrospective study. Eur Radiol 10.1007/s00330-01503924-8 [epub ahead of print on July 23, 2015]
3. Brenner B, Avivi I, Lishner M: Haematological cancers in pregnancy. Lancet 379:580-587, 2012
4. Bulas D, Egloff A: Benefits and risks of MRI in pregnancy. Semin Perinatol 37:301-304, 2013
5. Patenaude Y, Pugash D, Lim K, et al: Diagnostic Imaging Committee; Society of Obstetricians and Gynaecologists of Canada: The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can 36:349-363, 2014
6. Doll DC, Ringenberg QS, Yarbro JW: Management of cancer during pregnancy. Arch Intern Med 148:2058-2064, 1988
7. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet Oncol 5:283-291, 2004
8. Pereg D, Lishner M: Maternal and fetal effects of systemic therapy in the pregnant woman with cancer. Recent Results Cancer Res 178:21-38, 2008
9. Azim HA Jr., Pavlidis N, Peccatori FA: Treatment of the pregnantmotherwith cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II:Hematological tumors. Cancer Treat Rev 36:110-121, 2010
10. Smith D, Stevens J, Quinn J, et al: Myeloma presenting during pregnancy. Hematol Oncol 32: 52-55, 2014
11. Lammer EJ, Chen DT, Hoar RM, et al: Retinoic acid embryopathy. N Engl J Med 313:837-841, 1985
12. Streffer C, Shore R, Konermann G, et al: Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP 33:5-206, 2003
13. Otake M, Schull WJ: Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol 74: 159-171, 1998
14. International Commission on Radiological Protection: Pregnancy and medical radiation. Ann ICRP 30:iii-viii, 1-43, 2000
15. National Research Council Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington, DC, National Academies Press, 2006
16. Bednarz B, Xu XG:Monte Carlomodeling of a 6 and 18 MV Varian Clinac medical accelerator for infield and out-of-field dose calculations: development and validation. PhysMed Biol 54:N43-N57, 2009
17. D'Agostino E, Bogaerts R, Defraene G, et al: Peripheral doses in radiotherapy: A comparison between IMRT, VMAT and tomotherapy. Radiat Meas 57:62-67, 2013
18. La Tessa C, Berger T, Kaderka R, et al: Out-of-field dose studies with an anthropomorphic phantom: comparison of X-rays and particle therapy treatments. Radiother Oncol 105:133-138, 2012
19. Stovall M, Blackwell CR, Cundiff J, et al: Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group No. 36. Med Phys 22:63-82, 1995
20. [Erratum: Med Phys 22:1353-1354, 1995]
21. Matok I, Gorodischer R, Koren G, et al: The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 360:2528-2535, 2009
22. Einarson A, Maltepe C, Navioz Y, et al: The safety of ondansetron for nausea and vomiting of pregnancy: A prospective comparative study. BJOG 111:940-943, 2004
23. Einarson A, Shuhaiber S, Koren G: Effects of antibacterials on the unborn child: What is known and howshould this influence prescribing. Paediatr Drugs 3:803-816, 2001
24. Dale DC, Cottle TE, Fier CJ, et al: Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 72:82-93, 2003
25. Greer IA, Nelson-Piercy C: Low-molecularweight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106: 401-407, 2005
26. Evens AM, Advani R, Press OW, et al: Lymphoma occurring during pregnancy: Antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol 31:4132-4139, 2013
27. Bachanova V, Connors JM: How is Hodgkin lymphoma in pregnancy best treated? ASH Education Program Book 2008.1:33-34, 2008
28. Connors JM: Challenging problems: Coincident pregnancy, HIV infection, and older age. ASH Education Program Book 2008.1:334-339, 2008
29. Van Calsteren K, Heyns L, De Smet F, et al: Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683-689, 2010
30. Borchmann P, Eichenauer DA, Engert A: State of the art in the treatment of Hodgkin lymphoma. Nat Rev Clin Oncol 9:450-459, 2012
31. LishnerM, Zemlickis D, Degendorfer P, et al: Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 65:114-117, 1992
32. Kwee TC, Vermoolen MA, Akkerman EA, et al: Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study. J Magn Reson Imaging 40:26-36, 2014
33. Zanotti-Fregonara P, Koroscil TM, Mantil J, et al: Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy. Health Phys 102:217-219, 2012
34. Wang PH, Chao KC, Lin G, et al: Primary malignant lymphoma of the cervix in pregnancy. A case report. J Reprod Med 44:630-632, 1999
35. Kirkpatrick AW, Bailey DJ, Weizel HA: Bilateral primary breast lymphoma in pregnancy: A case report and literature review. Can J Surg 39:333-335, 1996
36. Horowitz NA, Benyamini N, Wohlfart K, et al: Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: A systematic review. Lancet Oncol 14:e275-e282, 2013
37. Amant F, Han SN, Gziri MM, et al: Management of cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol 29:741-753, 2015
38. Lishner M, Zemlickis D, Sutcliffe SB, et al: Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma 14:411-413, 1994
39. Zemlickis D, Lishner M, Degendorfer P, et al: Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152:573-576, 1992
40. Lam MS: Treatment of Burkitt's lymphoma during pregnancy. Ann Pharmacother 40:2048-2052, 2006
41. Peterson C, Lester DR, Jr., Sanger W: Burkitt's lymphoma in early pregnancy. J Clin Oncol 28: e136-e138, 2010
42. Hyoun SC, Običan SG, Scialli AR: Teratogen update: Methotrexate. Birth Defects Res A Clin Mol Teratol 94:187-207, 2012
43. Chakravarty EF, Murray ER, Kelman AJ, et al: Pregnancy outcomes after maternal exposure to rituximab. Blood 117:1499-1506, 2011
44. Apperley JF: Chronic myeloid leukaemia. Lancet 385:1447-1459, 2015
45. Nurmio M, Kallio J, Toppari J, et al: Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testis. Reprod Toxicol 25: 442-446, 2008
46. Pye SM, Cortes J, Ault P, et al: The effects of imatinib on pregnancy outcome. Blood 111:5505-5508, 2008
47. Milojkovic D, Apperley JF: How I treat leukemia during pregnancy. Blood 123:974-984, 2014
48. Harrison C: Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol 129:293-306, 2005
49. Yazdani Brojeni P, Matok I, Garcia Bournissen F, et al: A systematic review of the fetal safety of interferon a. Reprod Toxicol 33:265-268, 2012
50. Griesshammer M, Struve S, Barbui T: Management of Philadelphia negative chronicmyeloproliferative disorders in pregnancy. Blood Rev 22:235-245, 2008
51. Thauvin-Robinet C, Maingueneau C, Robert E, et al: Exposure to hydroxyurea during pregnancy: A case series. Leukemia 15:1309-1311, 2001
52. Barbui T, Finazzi G: Myeloproliferative disease in pregnancy and other management issues. Hematology (Am Soc Hematol Educ Program) 2006: 246-252, 2006
53. Griesshammer M, Grünewald M, Michiels JJ: Acquired thrombophilia in pregnancy: Essential thrombocythemia. Semin Thromb Hemost 29: 205-212, 2003
54. Willoughby SJ, Fairhead S, Woodcock BE, et al: Postpartum thrombosis in primary thrombocythaemia. Eur J Haematol 59:121-123, 1997
55. Robinson S, Bewley S, Hunt BJ, et al: The management and outcome of 18 pregnancies inwomen with polycythemia vera. Haematologica 90:1477-1483, 2005
56. Tulpule S, Bewley S, Robinson SE, et al: The management and outcome of four pregnancies in women with idiopathic myelofibrosis. Br J Haematol 142:480-482, 2008
57. Passamonti F, Randi ML, Rumi E, et al: Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V.F) mutation. Blood 110:485-489, 2007
58. Gangat N, Wolanskyj AP, Schwager S, et al: Predictors of pregnancy outcome in essential thrombocythemia:A single institution study of 63 pregnancies. Eur J Haematol 82:350-353, 2009
59. Cnossen JS, Morris RK, ter Riet G, et al: Use of uterine artery Doppler ultrasonography to predict preeclampsia and intrauterine growth restriction: A systematic review and bivariable meta-analysis. CMAJ 178:701-711, 2008
60. Llurba E, Carreras E, Gratacó s E, et al: Maternal history and uterine artery Doppler in the assessment of risk for development of early-and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int 2009:275613, 2009
61. Yahia C, Hyman GA, Phillips LL: Acute leukemia and pregnancy. Obstet Gynecol Surv 13:1-21, 1958
62. Catanzarite VA, Ferguson JE, II. Acute leukemia and pregnancy: A review of management and outcome, 1972-1982. Obstet Gynecol Surv 39:663-678, 1984
63. Haas JF: Pregnancy in association with a newly diagnosed cancer: A population-based epidemiologic assessment. Int J Cancer 34:229-235, 1984
64. Abadi U, Koren G, Lishner M: Leukemia and lymphoma in pregnancy. Hematol Oncol Clin North Am 25:277-291, 2011
65. Reynoso EE, Huerta F: Acute leukemia and pregnancy - fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 33:709-710, 1994
66. Koren G, Pastuszak A, Ito S: Drugs in pregnancy. N Engl J Med 338:1128-1137, 1998
67. Sanz MA, Grimwade D, Tallman MS, et al: Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 113:1875-1891, 2009
68. Sanfeliu C, Nebot-Cegarra J, Domenech-Mateu JM: Teratogenic effects of L-asparaginase in rat embryos in vitro. Acta Anat (Basel) 125:152-160, 1986
69. Sherer DM, Dalloul M, Santoso P, et al: Complete abortion of a nonviable cervical pregnancy followingmethotrexate treatment. AmJ Perinatol 21: 223-226, 2004
70. Osada S, Horibe K, Oiwa K, et al: A case of infantile acute monocytic leukemia caused by vertical transmission of the mother's leukemic cells. Cancer 65:1146-1149, 1990
71. Decker M, Went P: Placental barrier in acute myeloid leukemia. Br J Haematol 145:553, 2009
72. Amant F, von Minckwitz G, Han SN, et al: Prognosis of women with primary breast cancer diagnosed during pregnancy: Results from an international collaborative study. J Clin Oncol 31:2532-2539, 2013
73. Avilé s A, Neri N, Nambo MJ: Hematological malignancies and pregnancy: Treat or no treat during first trimester. Int J Cancer 131:2678-2683, 2012
74. Udink ten Cate FE, ten Hove CH, NixWM, et al: Transient neonatal myelosuppression after fetal exposure tomaternalchemotherapy.Casereportandreview of the literature. Neonatology 95:80-85, 2009
75. ChelghoumY, Vey N, Raffoux E, et al: Acute leukemia during pregnancy: A report on 37 patients and a reviewof the literature. Cancer 104:110-117, 2005
76. Park-Wyllie L, Mazzotta P, Pastuszak A, et al: Birthdefectsaftermaternalexposuretocorticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385-392, 2000
77. Diederich S, Eigendorff E, Burkhardt P, et al: 11b-Hydroxysteroid dehydrogenase types 1 and 2: An important pharmacokinetic determinant for the activity of synthetic mineralo-and glucocorticoids. J Clin Endocrinol Metab 87:5695-5701, 2002
78. Beitins IZ, Bayard F, Ances IG, et al: The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 81:936-945, 1972
79. Ballard PL, Granberg P, Ballard RA: Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 56:1548-1554, 1975
80. Moore LE, Martin JN Jr: When betamethasone and dexamethasone are unavailable: Hydrocortisone. J Perinatol 21:456-458, 2001
81. Rennick GJ: Use of systemic glucocorticosteroids in pregnancy: Be alert but not alarmed. Australas J Dermatol 47:34-36, 2006
82. Alexander A, Samlowski WE, Grossman D, et al: Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infant. J Clin Oncol 21:2179-2186, 2003
83. Gziri MM, Hui W, Amant F, et al: Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. Eur J Pediatr 172:163-170, 2013
84. Avilé s A, Neri N, Nambo MJ: Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 17: 286-288, 2006
85. Avilé s A, Neri N: Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2: 173-177, 2001
86. Doll R, Wakeford R: Risk of childhood cancer from fetal irradiation. Br J Radiol 70:130-139, 1997
87. Ray JG, Schull MJ, Urquia ML, et al: Major radiodiagnostic imaging in pregnancy and the risk of childhood malignancy: A population-based cohort study in Ontario. PLoS Med 7:e1000337, 2010
88. Rajaraman P, Simpson J, Neta G, et al: Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: Case-control study. BMJ 342:d472, 2011
89. Cardonick EH, Gringlas MB, Hunter K, et al: Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapyexposed children with nonexposed controls. Am J Obstet Gynecol 212:658.e1-658.e8, 2015
90. Amant F, Van Calsteren K, Halaska MJ, et al: Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: An observational study. Lancet Oncol 13:256-264, 2012
91. Amant F, Halaska MJ, Fumagalli M, et al: ESGO Task Force 'Cancer in Pregnancy': Gynecologic cancers in pregnancy: Guidelines of a second international consensus meeting. Int J Gynecol Cancer 24:394-403, 2014
92. Pistilli B, Bellettini G, Giovannetti E, et al: Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding. Cancer Treat Rev 39:207-211, 2013